PHAT Phathom Pharmaceuticals, Inc. - Common Stock
$9,67
Prix · Aoû 19, 2026
Données fondamentales au Jul 30, 2026
Fourchette 52 semaines
$8–$18
14% of range
Note des analystes
BUY
17 analysts
Objectif de cours
$22
+122% upside
P/E (TTM)
-3.5
ROE
52.4%
Marge nette
-126.4%
PHAT Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$9.67
Capitalisation Boursière
$768M
P/E (TTM)
-3.5
BPA (TTM)
$-3.03
Revenus (TTM)
$175M
Rendement div.
—
ROE
52.4%
Dette/Capitaux propres
-0.5
Fourchette 52 semaines
$8 – $18
PHAT Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$175M
2022-12-31
→
2025-12-31
BPA
$-3.03
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-167M
2019-12-31
→
2025-12-31
Marges
-126.4%
2023-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
PHAT
Médiane des pairs
P/E (TTM)
-3.5
11.7
P/S (TTM)
4.4
5.4
P/B
-1.8
3.7
EV / EBITDA
-5.3
—
Price / FCF (Cours / FCF)
-4.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
PHAT
Médiane des pairs
Gross Margin (Marge Brute)
87.1%
83.9%
Operating Margin (Marge d'exploitation)
-91.4%
—
Net Profit Margin (Marge nette)
-126.4%
-45.6%
ROA
-69.4%
-25.4%
ROE
52.4%
-27.1%
ROIC
69.8%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
PHAT
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
-0.5
—
Current Ratio (Ratio de liquidité)
1.7
4.6
Quick Ratio (Ratio de liquidité réduite)
1.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
PHAT
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
216.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
PHAT
Médiane des pairs
PHAT Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
17 analystes
- Achat fort 6 35,3%
- Achat 9 52,9%
- Conserver 2 11,8%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
10 analystes · 2026-08-18
Médiane
$21.50
← En dessous de tous les objectifs
$9.67
Bas
$13.00
Haut
$29.00
Objectif médian
$21.50
+122,3%
Objectif moyen
$21.50
+122,3%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.02%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.21 | $-0.26 | 0.05% |
| 31 mars 2026 | $-0.37 | $-0.33 | -0.04% |
| 31 décembre 2025 | $-0.29 | $-0.39 | 0.10% |
| 30 septembre 2025 | $-0.41 | $-0.56 | 0.15% |
| 30 juin 2025 | $-1.05 | $-1.06 | 0.01% |
| 31 mars 2025 | $-1.31 | $-1.17 | -0.14% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| SGP | — | — | — | — | 50.0% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
Bilan 24
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
Rentabilité 6
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $222M | $176M | · | $134M | $92M | $54M | · | $26M | $9M | $2M | · | · | · | · | |
| Net Income TTM | $-154M | $-230M | · | $-286M | $-347M | $-354M | · | $-303M | $-259M | $-205M | · | $-173M | $-181M | $-180M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -5.3 | -3.5 | · | -2.9 | -1.8 | -1.1 | · | -3.6 | -2.2 | -2.7 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.9 | 5.0 | · | 6.2 | 7.3 | 8.1 | · | 48.3 | 65.4 | 325.1 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| P / FCF | · | -56.2 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / EBITDA | -214.6 | -56.3 | · | -59.5 | -12.1 | -5.4 | · | -15.2 | -6.5 | -6.4 | · | -13.3 | -20.8 | -9.3 | |
| EV / FCF | · | -55.1 | · | · | · | -5.0 | · | · | · | -6.5 | · | · | · | -7.0 | |
| EV / Revenue | 3.8 | 4.9 | · | 6.8 | 7.9 | 7.9 | · | 42.1 | 54.3 | 234.5 | · | · | · | · | |
| Earnings Yield | -18.8% | -28.3% | · | -34.8% | -54.6% | -89.5% | · | -28.0% | -44.5% | -36.8% | · | -36.7% | -30.6% | -64.6% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $175M | $55M | $682.0K | $0 | — |
| Marge Brute % | 87.1% | 85.6% | 75.5% | — | — |
| Marge d'exploitation % | -91.4% | -502.2% | -24532.5% | — | — |
| Résultat net | $-221M | $-334M | $-202M | $-198M | $-144M |
| BPA dilué | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| Ratio de liquidité | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| Ratio de liquidité réduite | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-167M | $-267M | $-139M | $-148M | $-149M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 179 déclarants · $617.4M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 33 (+1 vs T. préc.) | 30 (-5 vs T. préc.) | 51 (-22 vs T. préc.) | 50 (+13 vs T. préc.) | +3.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135 261 406 | 12 466 489 | 21,91% | Actions |
| Medicxi Ventures Management (Jersey) Ltd | $80 990 606 | 7 464 572 | 13,12% | Actions |
| Carlyle Group Inc. | $37 940 367 | 3 496 808 | 6,15% | Actions |
| MILLENNIUM MANAGEMENT LLC | $36 627 799 | 3 375 834 | 5,93% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $28 827 842 | 2 656 944 | 4,67% | Actions |
| NEA Management Company, LLC | $21 267 834 | 1 960 169 | 3,44% | Actions |
| 683 Capital Management, LLC | $20 072 501 | 1 850 000 | 3,25% | Actions |
| STATE STREET CORP | $17 211 605 | 1 586 323 | 2,79% | Actions |
| Catalys Pacific, LLC | $16 208 316 | 1 493 854 | 2,63% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15 871 000 | 1 462 738 | 2,57% | Actions |
| GOLDMAN SACHS GROUP INC | $15 552 303 | 1 433 392 | 2,52% | Actions |
| WASATCH ADVISORS LP | $14 897 577 | 1 340 916 | 2,41% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $12 271 034 | 1 130 751 | 1,99% | Actions |
| Ensign Peak Advisors, Inc | $11 413 256 | 1 051 913 | 1,85% | Actions |
| Propel Bio Management, LLC | $11 396 384 | 1 050 358 | 1,85% | Actions |
| Point72 Asset Management, L.P. | $11 090 794 | 1 022 193 | 1,80% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 643 446 | 796 631 | 1,40% | Actions |
| SummitTX Capital, L.P. | $8 566 618 | 789 550 | 1,39% | Actions |
| EcoR1 Capital, LLC | $6 781 250 | 625 000 | 1,10% | Actions |
| PERCEPTIVE ADVISORS LLC | $5 772 200 | 532 000 | 0,93% | Actions |
| TWO SIGMA INVESTMENTS, LP | $5 631 975 | 519 076 | 0,91% | Actions |
| CITADEL ADVISORS LLC | $5 216 680 | 480 800 | 0,84% | Option d'achat |
| VANGUARD GROUP INC | $4 969 501 | 299 548 | 0,80% | Actions |
| StepStone Group LP | $4 689 364 | 422 085 | 0,76% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 547 170 | 419 094 | 0,74% | Actions |
| Woodline Partners LP | $4 004 214 | 369 052 | 0,65% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $3 847 117 | 354 573 | 0,62% | Actions |
| AMERIPRISE FINANCIAL INC | $3 189 358 | 293 950 | 0,52% | Actions |
| Simplify Asset Management Inc. | $2 704 547 | 249 267 | 0,44% | Actions |
| JPMORGAN CHASE & CO | $2 616 050 | 240 667 | 0,42% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $2 456 440 | 226 400 | 0,40% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 281 755 | 210 300 | 0,37% | Option d'achat |
| NewEdge Advisors, LLC | $2 212 988 | 203 962 | 0,36% | Actions |
| Avidity Partners Management LP | $2 170 000 | 200 000 | 0,35% | Actions |
| Jump Financial, LLC | $2 081 746 | 191 866 | 0,34% | Actions |
| Opaleye Management Inc. | $2 013 641 | 185 589 | 0,33% | Actions |
| CITADEL ADVISORS LLC | $2 006 176 | 184 901 | 0,32% | Actions |
| Trexquant Investment LP | $1 886 641 | 173 884 | 0,31% | Actions |
| Jones Hill Capital LP | $1 752 123 | 161 486 | 0,28% | Actions |
| MARSHALL WACE, LLP | $1 751 191 | 161 400 | 0,28% | Actions |
| XTX Topco Ltd | $1 473 777 | 135 832 | 0,24% | Actions |
| DIADEMA PARTNERS LP | $1 409 958 | 129 950 | 0,23% | Actions |
| SIG BROKERAGE, LP | $1 345 400 | 124 000 | 0,22% | Option d'achat |
| Engineers Gate Manager LP | $1 283 088 | 118 257 | 0,21% | Actions |
| Virtus Investment Advisers, LLC | $1 216 708 | 112 139 | 0,20% | Actions |
| BANK OF AMERICA CORP /DE/ | $1 178 885 | 108 653 | 0,19% | Actions |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1 105 968 | 101 745 | 0,18% | Actions |
| JANE STREET GROUP, LLC | $1 096 761 | 101 084 | 0,18% | Actions |
| Stratos Wealth Partners, LTD. | $1 085 000 | 100 000 | 0,18% | Actions |
| Swiss National Bank | $1 071 980 | 98 800 | 0,17% | Actions |
| GILDER GAGNON HOWE & CO LLC | $956 254 | 88 134 | 0,15% | Actions |
| Stonepine Capital Management, LLC | $922 358 | 85 010 | 0,15% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $838 879 | 77 316 | 0,14% | Actions |
| JANE STREET GROUP, LLC | $837 620 | 77 200 | 0,14% | Option d'achat |
| BlackRock, Inc. | $835 548 | 77 009 | 0,14% | Actions |
| Campbell & CO Investment Adviser LLC | $746 035 | 68 759 | 0,12% | Actions |
| Penn Mutual Asset Management | $681 402 | 62 802 | 0,11% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $675 771 | 62 283 | 0,11% | Actions |
| RHUMBLINE ADVISERS | $654 740 | 60 346 | 0,11% | Actions |
| UBS Group AG | $635 105 | 58 535 | 0,10% | Actions |
| Birchview Capital, LP | $596 750 | 55 000 | 0,10% | Actions |
| D. E. Shaw & Co., Inc. | $585 206 | 53 936 | 0,09% | Actions |
| ALLIANCEBERNSTEIN L.P. | $547 612 | 49 290 | 0,09% | Actions |
| CITIGROUP INC | $543 661 | 50 107 | 0,09% | Actions |
| Bank of New York Mellon Corp | $540 037 | 49 773 | 0,09% | Actions |
| Pale Fire Capital SE | $539 386 | 49 713 | 0,09% | Actions |
| NOMURA HOLDINGS INC | $532 735 | 49 100 | 0,09% | Option de vente |
| Man Group plc | $528 167 | 48 679 | 0,09% | Actions |
| AlphaQuest LLC | $468 668 | 28 250 | 0,08% | Actions |
| ADAR1 Capital Management, LLC | $465 465 | 42 900 | 0,08% | Actions |
| Quantbot Technologies LP | $463 892 | 42 755 | 0,08% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $459 866 | 42 384 | 0,07% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446 866 | 40 222 | 0,07% | Actions |
| BARCLAYS PLC | $435 660 | 40 153 | 0,07% | Actions |
| NOMURA HOLDINGS INC | $434 000 | 40 000 | 0,07% | Actions |
| Y-Intercept (Hong Kong) Ltd | $432 318 | 39 845 | 0,07% | Actions |
| Fiduciary Trust Co | $387 681 | 35 731 | 0,06% | Actions |
| Nebula Research & Development LLC | $363 816 | 37 937 | 0,06% | Actions |
| Persistent Asset Partners Ltd | $359 753 | 33 157 | 0,06% | Actions |
| ALLSTATE CORP | $356 694 | 32 875 | 0,06% | Actions |
| Squarepoint Ops LLC | $342 806 | 31 595 | 0,06% | Actions |
| CITADEL ADVISORS LLC | $337 435 | 31 100 | 0,05% | Option de vente |
| VANGUARD ASSET MANAGEMENT, Ltd | $309 290 | 28 506 | 0,05% | Actions |
| MetLife Investment Management, LLC | $304 961 | 28 107 | 0,05% | Actions |
| Kera Capital Partners, Inc. | $291 062 | 26 826 | 0,05% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $280 342 | 25 838 | 0,05% | Actions |
| Caption Management, LLC | $260 400 | 24 000 | 0,04% | Option d'achat |
| Caption Management, LLC | $260 400 | 24 000 | 0,04% | Option de vente |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $245 720 | 22 647 | 0,04% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $244 500 | 22 535 | 0,04% | Actions |
| Summit Financial Wealth Advisors, LLC | $240 252 | 22 143 | 0,04% | Actions |
| JANUS HENDERSON GROUP PLC | $239 403 | 21 500 | 0,04% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $236 198 | 18 731 | 0,04% | Actions |
| Vanguard Global Advisers, LLC | $225 344 | 20 769 | 0,04% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220 255 | 20 300 | 0,04% | Option de vente |
| Invesco Ltd. | $211 065 | 19 453 | 0,03% | Actions |
| INSPIRION WEALTH ADVISORS, LLC | $209 794 | 19 914 | 0,03% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $192 316 | 17 725 | 0,03% | Actions |
| State of Wyoming | $191 383 | 17 639 | 0,03% | Actions |
| PROFUND ADVISORS LLC | $187 455 | 17 277 | 0,03% | Actions |
Initiés de la société 20 initiés · 9 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 10 février 2026 F | 373 315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 7 avril 2025 S | 89 868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 28 janvier 2021 A | — | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 27 février 2025 A | 360 465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 27 février 2025 A | 312 590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 14 juillet 2026 F | 59 925 | 0 | 2 | $-12 652 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 10 février 2026 F | 88 660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 2 janvier 2026 A | 226 715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 19 janvier 2022 A | 8 399 | 0 | 0 | $0 |
| Asit Parikh | Administrateur | 22 mai 2026 G | 148 500 | 0 | 0 | $0 |
| Mark Stenhouse | Administrateur | 19 mai 2026 A | 54 122 | 0 | 0 | $0 |
| Theodore R Schroeder | Administrateur | 19 mai 2026 A | 45 122 | 0 | 0 | $0 |
| James N. Topper | Administrateur | 19 mai 2026 A | 66 718 | 0 | 0 | $0 |
| Frank Karbe | Administrateur | 19 mai 2026 A | 91 622 | 0 | 0 | $0 |
| Michael F Cola | Administrateur | 19 mai 2026 A | 63 920 | 0 | 0 | $0 |
| Heidi Kunz | Administrateur | 19 mai 2026 A | 54 122 | 0 | 0 | $0 |
| David A Socks | Administrateur | 23 mai 2024 A | 19 500 | 0 | 0 | $0 |
| Tadataka Yamada | Administrateur | 21 mai 2021 A | — | 0 | 0 | $0 |
| Jonathan S. Edwards | Administrateur | 29 octobre 2019 C | 47 984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | — | 24 janvier 2024 S | 3 755 583 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 dépôts | 4 novembre 2025 | 8,60% | Amendement | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 dépôts | 22 août 2024 | — | Dépôt initial | Investissement passif | SEC |
| Takeda Pharmaceutical Company Limited ×3 dépôts | 10 avril 2024 | — | Dépôt initial | — | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 26 mai 2023 | — | Dépôt initial | Investissement passif | SEC |
| S.S. OR ×5 dépôts | 12 novembre 2021 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 34 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,23% | 64 997 NS | 30 avril 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,01% | 11 659 NS | 30 avril 2026 | N-PORT |
| IHE · iShares Trust | 0,09% | 182 732 SH | 8 août 2026 | Quotidien |
| IWC · iShares Trust | 0,09% | 166 627 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 49 552 NS | 31 mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 4 339 SH | 8 août 2026 | Quotidien |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 78 352 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,04% | 2 912 NS | 31 mai 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 414 853 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 283 184 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30 521 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,02% | 329 427 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,02% | 20 112 NS | 30 avril 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 18 573 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,01% | 1 253 335 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,01% | 2 182 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 586 438 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 15 003 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 148 237 SH | 8 août 2026 | Quotidien |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236 650 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 21 971 NS | 30 avril 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2 641 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,01% | 129 591 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,01% | 1 707 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 727 NS | 31 mai 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2 570 SH | 8 août 2026 | Quotidien |
| HDG · ProShares Trust | 0,00% | 43 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 333 NS | 31 mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 205 NS | 31 mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79 259 SH | 8 août 2026 | Quotidien |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 33 490 NS | 31 mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9 288 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 007 668 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 478 SH | 8 août 2026 | Quotidien |